TPG-backed drugmaker Aptalis files for IPO of up to $500 mln

Dec 26 (Reuters) - Specialty drugmaker Aptalis Holdings Inc, owned by private equity firm TPG Capital LP, filed with U.S. regulators to raise up to $500 million in an initial public offering of its...

from Reuters: Bonds News http://feeds.reuters.com/~r/reuters/bondsNews/~3/JO4uGTFCpGQ/story01.htm